Abstract
Neuroblastoma (NB) is characterized by acquired segmental and numerical chromosome aberrations. Although deletions of distal 1p and 11q are frequent alterations, no candidate tumor suppressor gene residing in these chromosomal sites could be identified so far. In the present study, we detected the genomic imbalances of six neuroblastoma cell lines using the multiplex ligation-dependent probe amplification (MLPA) technique and the microRNA (miRNA) expression profiles of the cell lines by a microarray study. According to MLPA results, we aimed to assess the miRNA expression profiles of the cell lines harboring 11q and 1p deletions. The cell lines with 1p deletions revealed statistically significant higher levels of expression for 29 miRNAs in contrast to the cell lines without 1p deletion in microarray study. We also performed GO enrichment analysis for predicted targets of the differentially expressed miRNAs. According to GO enrichment analysis, miRNAs that showed the high change in expression was associated with neuronal differentiation. We showed that hsa-miR-494, hsa-miR-495, and hsa-miR-543 target most of mRNAs in neuronal differentiation pathway. Although limited to the cell lines, our results highly suggest that NBs with different segmental chromosome abnormalities may have different dysregulated miRNA expression signatures that target the genes involved in neuronal differentiation.
Similar content being viewed by others
Data Availability
The all datasets supporting the findings of this study are available within the article and its supplementary information files.
References
Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Benard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N, Jeison M, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Speleman F, Stallings R, Tonini GP, Tweddle DA, Valent A, Aleš V, Van Roy N, Villamon E, Ziegler A, Preuner S, Drobics M, Ladenstein R, Amann G, Schuit RJL, Potschger U, Ambros PF (2011) A multilocus technique for risk evaluation of patients with neuroblastoma. Clin Cancer Res 17:792–804
Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM (2005) Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 353:2243–2253
Bader SA, Fasching C, Brodeur GM, Stanbridge EJ (1991) Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 2:245–255
Barbarotto E, Secchiero P, Dasgupta A, Fortina P, Calin GA, Hyslop T (2008) MicroRNAs as new players in the genomic galaxy and disease puzzles. Clin Transl Sci 1:50–56
Beckers A, Van Peer G, Carter DR, Althoff K, Cheung BB, Schulte JH, Mestdag P, Vandesompele J, Marshall GM, De Preter K (2015) MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation. Oncotarget 6:5204–5216
Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36:D149–D153
Biedler JL, Helson L, Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Can Res 33(11):2643–2652
Bown N (2001) Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol 54:897–910
Bown N, Cotterill S, Lastowska M, O’Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F (1999) Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. NEnglJMed 340:1954–1961
Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Boecker W, Lampert F, Stoerkel S (1997) Comparative genomic hybridization (CGH) analysis of neuroblastomas–an important methodological approach in paediatric tumour pathology. J Pathol 181:394–400
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rais K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99:15524-9
Caron H (1995) Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 24:215–221
Caron H, Van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voûte PA, Westerveld A, Versteeg R (1993) Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 2:187–190
Castleberry RP (1997) Neuroblastoma. Eur J Cancer 33:1430–1437
Check E (2007) RNA interference: hitting the on switch. Nature 448:855–858
Chédotal A, Kerjan G, Moreau-Fauvarque C (2005) The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ 12:1044–1056
Chen Y, Stallings RL (2007) Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 67:976–983
Dalmay T, Edwards DR (2006) MicroRNAs and the hallmarks of cancer. Oncogene 25:61706175
Dalmay T (2008) MicroRNAs and cancer. J Intern Med 263:366–375
De Preter K, Vandesompele J, Heimann P, Yigit N, Beckman S, Schramm A, Eggert A, Stallings RL, Benoit Y, Renard M, Paepe AD, Laureys G, Pahlman S, Speleman F (2006) Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol 7:R84
Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, Chaplin T, Andrew Lister T, Young BD, Debernardi S (2008) Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS ONE 3:e2141
Edsjö A, Nilsson H, Vandesompele J, Karlsson J, Pattyn F, Culp LA, Speleman F, Påhlman S (2004) Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation. Lab Invest 84:406–417
Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM (1992) Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 52:1780–1785
Gattolliat CH, Thomas L, Ciafrè SA, Meurice G, Le Teuff G, Job B, Richon C, Combaret V, Dessen P, Valteau-Couanet D, May E, Busson P, Douc-Rasy S, Bénard J (2011) Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. Br J Cancer 105:1352–1361
Genovesi LA, Carter KW, Gottardo NG, Giles KM, Dallas PB (2011) Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells. PLoS ONE 6:e23935
Gennarino VA, D’Angelo G, Dharmalingam G, Fernandez S, Russolillo G, Sanges R, Mutarelli M, Belcastro V, Ballabio A, Verde P, Sardiello M, Banfi S (2012) Identification of microRNAregulated gene networks by expression analysis of target genes. Genome Res 22:1163–1172
Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36:D154–D158
Haller F, von Heydebreck A, Zhang JD, Gunawan B, Langer C, Ramadori G, Wiemann S, Sahin O (2010) Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. J Pathol 220:71–86
Hellmann J, Rommelspacher H, Wernicke C (2009) Long-term ethanol exposure impairs neuronal differentiation of human neuroblastoma cells involving neurotrophin-mediated intracellular signaling and in particular protein kinase C. Alcohol Clin Exp Res 33:538–550
Henrich KO, Claas A, Praml C, Benner A, Mollenhauer J, Poustka A, Schwab M, Westermann F (2007) Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma. Eur J Cancer 43:607–616
Hill DP, Robertson KA (1997) Characterization of the cholinergic neuronal differentiation of the human neuroblastoma cell line LA-N-5 after treatment with retinoic acid. Brain Res Dev Brain Res 102:53–67
Hinck L (2004) The versatile roles of “axon guidance” cues in tissue morphogenesis. Dev Cell 7:783–793
Huber K, Karch N, Ernsberger U, Goridis C, Unsicker K (2005) The role of Phox2B in chromaffin cell development. Dev Biol 279:501–508
Jia L, Cheng L, Raper J (2005) Slit/Robo signaling is necessary to confine early neural crest cells to the ventral migratory pathway in the trunk. Dev Biol 282:411–421
Kawasaki H, Wadhwa R, Taira K (2004) World of small RNAs: from ribozymes to siRNA and miRNA. Differentiation 72:58–64
Lastowska M, Nacheva E, McGuckin A, Curtis A, Grace C, Pearson A, Bown N (1997) Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children’s Cancer Study Group. Genes Chromosomes Cancer 18:162–169
Le Douarin N, Dulac C, Dupin E, Cameron-Curry P (1991) Glial cell lineages in the neural crest. Glia 4:175–184
Le Douarin NM, Smith J, Le Lièvre CS (1981) From the neural crest to the ganglia of the peripheral nervous system. Annu Rev Physiol 43:653–671
Lee S, Yoon DS, Paik S, Lee KM, Jang Y, Lee JW (2014) microRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9. Stem Cells Dev 23:1798–1808
Li W, Cogswell CA, LoTurco JJ (1998) Neuronal differentiation of precursors in the neocortical ventricular zone is triggered by BMP. J Neurosci 18:8853–8862
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408
Manohar CF, Furtado MR, Salwen HR, Cohn SL (1993) Hox gene expression in differentiating human neuroblastoma cells. Biochem Mol Biol Int 30:733–741
Marini P, MacLeod RA, Treuner C, Bruchelt G, Bohm W, Wolburg H, Schweizer P, Girgert R (1999) SiMa, a new neuroblastoma cell line combining poor prognostic cytogenetic markers with high adrenergic differentiation. Cancer Genet Cytogenet 112(2):161–164
Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369:2106–2120
Matzke M, Aufsatz W, Kanno T, Daxinger L, Papp I, Mette MF, Matzke AJ (2004) Genetic analysis of RNA-mediated transcriptional gene silencing. Biochim Biophys Acta 1677:129–141
Mavilio F, Simeone A, Boncinelli E, Andrews PW (1988) Activation of four homeobox gene clusters in human embryonal carcinoma cells induced to differentiate by retinoic acid. Differentiation 37:73–79
Nakagawara A (1998) Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum Cell 11:115–124
Nakagawara A, Ohira M (2004) Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model. Cancer Lett 204:213–224
Obernosterer G, Leuschner PJ, Alenius M, Martinez J (2006) Post-transcriptional regulation of microRNA expression. RNA 12:1161–1167
Ohira M, Morohashi A, Inuzuka H, Shishikura T, Kawamoto T, Kageyama H, Nakamura Y, Isogai E, Takayasu H, Sakiyama S, Suzuki Y, Sugano S, Goto T, Sato S, Nakagawara A (2003) Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets. Oncogene 22:5525–5536
Ohira M, Shishikura T, Kawamoto T, Inuzuka H, Morohashi A, Takayasu H, Kageyama H, Takada N, Takahashi M, Sakiyama S, Suzuki Y, Sugano S, Kuma H, Nozawa I, Nakagawara A (2000) Hunting the subset-specific genes of neuroblastoma: expression profiling and differential screening of the full-length-enriched oligo-capping cDNA libraries. Med Pediatr Oncol 35:547–549
Panchision DM, Pickel JM, Studer L, Lee SH, Turner PA, Hazel TG, McKay RD (2001) Sequential actions of BMP receptors control neural precursor cell production and fate. Genes Dev 15:2094–2110
Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF (1999) The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 399:366–370
Pietsch T, Gottert E, Meese E, Blin N, Feickert HJ, Riehm H, Kovacs G (1988) Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastoma. Anticancer Res 8(6):1329–1333
Preis PN, Saya H, Nádasdi L, Hochhaus G, Levin V, Sadée W (1988) Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A. Cancer Res 48:6530–6534
Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG (2012) Functional microRNA targets in protein coding sequences. Bioinformatics 28:771–776
Ritke MK, Shah R, Valentine M, Douglass EC, Tereba A (1989) Molecular analysis of chromosome 1 abnormalities in neuroblastoma. Cytogenet Cell Genet 50:84–90
Schleiermacher G, Janoueix-Lerosey I, Delattre O (2014) Recent insights into the biology of neuroblastoma. Int J Cancer 135:2249–2261
Schlesinger HR, Gerson JM, Moorhead PS, Maguire H, Hummeler K (1976) Establishment and characterization of human neuroblastoma cell lines. Cancer Res 36(9pt.1):3094–3100
Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305(5931):245–248
Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q, Wei Q, Li X, Wang J, Zeng H (2014) MicroRNA494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer. Prostate 74:756–767
Shih YY, Lee H, Nakagawara A, Juan HF, Jeng YM, Tsay YG, Lin DT, Hsieh FJ, Pan CY, Hsu WM, Liao YF (2011) Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma. PLoS ONE 6:e26236
Sidell N (1982) Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 68:589–596
Simeone A, Acampora D, Nigro V, Faiella A, D’Esposito M, Stornaiuolo A, Mavilio F, Boncinelli E (1991) Differential regulation by retinoic acid of the homeobox genes of the four HOX loci in human embryonal carcinoma cells. Mech Dev 33:215–227
Song L, Liu D, Wang B, He J, Zhang S, Dai Z, Ma X, Wang X (2015) miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway. Oncol Rep 34:525–531
Stallings RL, Howard J, Dunlop A, Mullarkey M, McDermott M, Breatnach F, O’Meara A (2003) Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma? Cancer Genet Cytogenet 140:133–137
Tang G, Dong X, Huang X, Huang XJ, Liu H, Wang Y, Ye WC, Shi L (2015) A natural diarylheptanoid promotes neuronal differentiation via activating ERK and PI3K-Akt dependent pathways. Neurosci 303:389–401
Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing R, Matthay KK, Matise TC, White PS (2001) Loss of heterozygosity for chromosome 14q in neuroblastoma. Med Pediatr Oncol 36:28–31
Tumilowicz JJ, Nichols WW, Cholon JJ, Greene AE (1970) Definition of a continuous human cell line derived from neuroblastoma. Can Res 30(8):2110–2118
Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gyselinck J, De Paepe A, Speleman F (1998) Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 23:141–152
Wang X, Yang L, Choi JH, Kitamura E, Chang CS, Ding J, Lee EJ, Cui H, Ding HF (2014) Genome-wide analysis of HOXC9-induced neuronal differentiation of neuroblastoma cells. Genom Data 2:50–52
Yang D, Wang G, Zhu S, Liu O, Wei T, Leng Y, Duan T, Kang J (2014) MiR-495 suppresses mesendoderm differentiation of mouse embryonic stem cells via the direct targeting of Dnmt3a. Stem Cell Research 12:550–561
Zehir A, Hua LL, Maska EL, Morikawa Y, Cserjesi P (2010) Dicer is required for survival of differentiating neural crest cells. Dev Biol 340:459–467
Zha Y, Ding E, Yang L, Mao L, Wang X, McCarthy BA, Huang S, Ding HF (2012) Functional dissection of HOXD cluster genes in regulation of neuroblastoma cell proliferation and differentiation. PLoS ONE 7:e40728
Funding
This study was sponsored by the Dokuz Eylül University Research Fund, Project 2009.KB.SAG. 021 (to Oguz Altungoz).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bagci, O., Tumer, S. & Altungoz, O. Chromosome 1p status in neuroblastoma correlates with higher expression levels of miRNAs targeting neuronal differentiation pathway. In Vitro Cell.Dev.Biol.-Animal 59, 100–108 (2023). https://doi.org/10.1007/s11626-023-00750-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-023-00750-w